| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000336087 |
| P698 | PubMed publication ID | 22456267 |
| P2093 | author name string | Catharina Larsson | |
| P2860 | cites work | miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer | Q45119395 |
| A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis | Q46050836 | ||
| Deregulation of both imprinted and expressed alleles of the insulin–like growth factor 2 gene during β–cell tumorigenesis | Q46146329 | ||
| Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. | Q48096674 | ||
| Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma | Q48100816 | ||
| Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis. | Q52575556 | ||
| Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. | Q54447289 | ||
| Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. | Q54738057 | ||
| Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
| Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression | Q24297027 | ||
| Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus | Q24313196 | ||
| The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores | Q24649374 | ||
| Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene | Q28145754 | ||
| Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1 | Q28243243 | ||
| Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene | Q28249576 | ||
| Positional cloning of the gene for multiple endocrine neoplasia-type 1 | Q28307577 | ||
| Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c | Q28506197 | ||
| Hypomethylation distinguishes genes of some human cancers from their normal counterparts | Q29619217 | ||
| Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma | Q30320562 | ||
| Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes | Q33366330 | ||
| Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells | Q33998266 | ||
| Guidelines for diagnosis and therapy of MEN type 1 and type 2. | Q34104591 | ||
| The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma | Q34209973 | ||
| A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript. | Q35288950 | ||
| Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis | Q36324689 | ||
| Epigenetic therapy of cancer: past, present and future | Q36399557 | ||
| IGF2: epigenetic regulation and role in development and disease | Q36561897 | ||
| Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk | Q36693375 | ||
| Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective | Q37347306 | ||
| Multiple endocrine neoplasia type 1: a chromatin writer's block. | Q37517691 | ||
| Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling | Q38442944 | ||
| Oncogenic role of miR-483-3p at the IGF2/483 locus | Q39715206 | ||
| KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model. | Q39871460 | ||
| Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors | Q40127683 | ||
| Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). | Q40136348 | ||
| Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells | Q40198503 | ||
| Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. | Q40463075 | ||
| Varying Opinions on the Authenticity of a Human Midgut Carcinoid Cell Line – Letter | Q42815034 | ||
| Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes | Q43470250 | ||
| MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases | Q44303888 | ||
| CpG island methylation in carcinoid and pancreatic endocrine tumors | Q44313522 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 19-25 | |
| P577 | publication date | 2012-03-24 | |
| P1433 | published in | Neuroendocrinology | Q2410309 |
| P1476 | title | Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors | |
| P478 | volume | 97 |
| Q38272919 | Epigenetic changes in gastroenteropancreatic neuroendocrine tumours |
| Q47393972 | Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets |
| Q38132768 | Targeting the somatostatin receptor in pituitary and neuroendocrine tumors |
| Q33709979 | The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors |
Search more.